News

Context Therapeutics Inc. (NASDAQ: CNTX) shares closed down 27% at $0.50 after the company disclosed a second-quarter net loss of $14.6 million, compared to $8.8 million in the prior year, driven by intensified R&D investment to progress its bispecific antibody portfolio.

BillionToOne, Inc. (NASDAQ: BLLN) shares closed down 39% at $91.65 despite the company disclosing second-quarter revenue of $109.45 million, representing a robust 64% year-over-year increase fueled by a 35% rise in test volume and a 21% improvement in average selling price to $551.

CVRx, Inc. (NASDAQ: CVRX) shares were weighed down after the company announced that second-quarter 2026 revenue rose 16% to $15.7 million, with U.S. Barostim sales up 21% and gross margin expanding to 87%.

BioVie Inc. (NASDAQ: BIVI) shares closed down 34% at $1.35 even after the company reported Phase 2 SUNRISE-PD data for bezisterim in early Parkinson's disease that met primary endpoints.

Replimune Group, Inc. (NASDAQ: REPL) shares closed up 9% at $12.86 after the company disclosed that the FDA has granted accelerated approval for TUDRIQEV in combination with nivolumab for the treatment of patients with unresectable advanced cutaneous melanoma following anti-PD-1 progression.

• Senseonics shares climbed approximately 36.31 percent to $7.02, a gain of $1.87 from a prior close of $5.15.

• ServiceNow shares climbed approximately 6.42 percent to $124.88, a gain of $7.53 from a prior close of $117.35.